Hiltonol (poly-ICLC)
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Hiltonol (poly-ICLC), covering 2025-03-21 to 2026-02-27. Get the full timeline:
Most recent: Clinical Trial Update: DEC-205/NY-ESO-1 Fusion Protein CDX-1401, Poly ICLC, Decitabine, and Nivolumab in Treating Patients With Myelodysplastic Syndrome or Acute Myeloid Leukemia [Phase 1]